Dysmorphic megakaryocytes in TAFRO syndrome: A case series from a single institute
Blood Cells, Molecules, and Diseases · 2024
DOI: 10.1016/j.bcmd.2024.102870 ↗Kurz gefasst
Fallbericht in der Zeitschrift Blood Cells, Molecules, and Diseases, 2024. Verfasst von Shohei Maida und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Laboratory Medicine, Hiroshima University Hospital, Hiroshima, Japan. Hauptthemen laut MEDLINE: Castleman Disease, Megakaryocytes. Die Arbeit nennt 18 Literaturangaben.
Abstract (Originalsprache)
TAFRO syndrome is a rare systemic inflammatory disorder of unknown etiology characterized by thrombocytopenia, anasarca, fever, reticulin myelofibrosis, renal dysfunction, and organomegaly. The diagnosis of TAFRO syndrome can be challenging; however, prompt diagnosis is vital because TAFRO syndrome is a progressive and life-threatening disease. We have showcased five patients with TAFRO syndrome who had similar bone marrow (BM) findings that could be considered the findings that characterize TAFRO syndrome. All patients were treated with corticosteroids and tocilizumab; three of the five patients (60 %) responded positively to the treatment. The unique BM findings observed in this study were megakaryocytes with distinct multinuclei and three-dimensional and indistinct bizarre nuclei ("dysmorphic megakaryocyte"), similar to the megakaryocyte morphology observed in myeloproliferative neoplasms (MPNs). Notably, dysmorphic megakaryocytes were observed in all five cases, whereas only two of the five patients tested positive for reticulin myelofibrosis, and three of the five patients had megakaryocytic hyperplasia, which are considered typical findings of TAFRO syndrome. Thus, the BM findings of dysmorphic megakaryocytes could help in the correct and immediate diagnosis of TAFRO syndrome.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Laboratory Medicine, Hiroshima University Hospital, Hiroshima, Japan.
- Medical Support Department, Hiroshima University Hospital, Hiroshima, Japan.
- Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan. Electronic address: hureshin@hiroshima-u.ac.jp.
- Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
Zitieren
APA
Maida, S., Nakagawa, H., Ureshino, H., Kajihara, K., Yamazaki, S., & Ichinohe, T. (2024). Dysmorphic megakaryocytes in TAFRO syndrome: A case series from a single institute. Blood Cells, Molecules, and Diseases. https://doi.org/10.1016/j.bcmd.2024.102870
Vancouver
Maida S, Nakagawa H, Ureshino H, Kajihara K, Yamazaki S, Ichinohe T. Dysmorphic megakaryocytes in TAFRO syndrome: A case series from a single institute. Blood Cells, Molecules, and Diseases. 2024. doi:10.1016/j.bcmd.2024.102870
BibTeX
@article{Maida2024,
author = {Maida, Shohei and Nakagawa, Hiromi and Ureshino, Hiroshi and Kajihara, Kyoko and Yamazaki, Shinichi and Ichinohe, Tatsuo},
title = {Dysmorphic megakaryocytes in TAFRO syndrome: A case series from a single institute},
journal = {Blood Cells, Molecules, and Diseases},
year = {2024},
doi = {10.1016/j.bcmd.2024.102870}
}
EUVIMED